MAHLY (Medipal Holdings) Interest Expense: $-0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MAHLY Medipal Holdings Corp MAHLY
82 GF Score
Price $17.99
GF Value $16.38
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Medipal Holdings Interest Expense?

Medipal Holdings MAHLY 82 Interest Expense is $-0 Mil as of Mar. 2026. GuruFocus rates MAHLY with a GF Score™ of 82/100 and a GF Value™ of $16.38 (Fairly Valued). The stock has 1 warning sign investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Medipal Holdings's interest expense for the three months ended in Mar. 2026 was $ -0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Medipal Holdings's Operating Income for the three months ended in Mar. 2026 was $ 63 Mil. Medipal Holdings's Interest Expense for the three months ended in Mar. 2026 was $ -0 Mil. Medipal Holdings's Interest Coverage for the quarter that ended in Mar. 2026 was 2,520.24. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medipal Holdings  (OTCPK:MAHLY) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medipal Holdings's Interest Expense for the three months ended in Mar. 2026 was $-0 Mil. Its Operating Income for the three months ended in Mar. 2026 was $63 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $0 Mil.

Medipal Holdings's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*63.006/-0.025
=2,520.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Medipal Holdings Corp has no debt.

Medipal Holdings Interest Expense Historical Data

* Premium members only.

The historical data trend for Medipal Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medipal Holdings Interest Expense Chart

Medipal Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.14 -0.25 -0.05 -0.05 -0.08

Medipal Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.02 -0.02 -0.02 -0.03
MAHLY
82GF Score
Medipal Holdings Corp MAHLY
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medipal Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0 Mil mean?
Medipal Holdings (MAHLY) has a Interest Expense of $-0 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Medipal Holdings and its competitors.
Is Medipal Holdings' Interest Expense too high?
Medipal Holdings' current Interest Expense is $-0 Mil. Overall, Medipal Holdings has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Interest Expense compare to MCK and CAH?
Medipal Holdings' Interest Expense of $-0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Distribution company?
A good Interest Expense depends on the Medical Distribution industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Medipal Holdings and its competitors. Medipal Holdings's current Interest Expense is $-0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (MAHLY) is currently considered Fairly Valued. The stock's GF Value™ is $16.38, compared to a current price of $17.99 — trading 9.8% above its estimated fair value. The current Interest Expense is $-0 Mil. Medipal Holdings' overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Medipal Holdings (MAHLY), the current Interest Expense is $-0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medipal Holdings (MAHLY) Overvalued in 2026?

Based on GuruFocus' analysis, Medipal Holdings stock appears to be overvalued. The current stock price of $17.99 is trading 9.8% above its estimated GF Value™ of $16.38. GuruFocus considers Medipal Holdings to be Fairly Valued.

Key valuation signals for MAHLY:

  • Interest Expense: $-0 Mil
  • GF Value™: $16.38 vs. price of $17.99 (9.8% above fair value)
  • GF Score™: 82/100 with 1 warning sign

No single metric tells the full story. See the MAHLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medipal Holdings Business Description

Other Exchanges MEPDF:USA7459:Japan
Address 3-1-1 Kyobashi, Chuo-ku, Tokyo, JPN, 104-8461
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
82GF Score

Get the complete analysis for MAHLY

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.99
Price
$16.38
GF Value